Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed May 5, 2016 · 10-Q · 35 days after period end · 0001564590-16-017783
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Net Income | -$59.77M | -$61.56M | -$28.27M | -$42.08M |
| EPS Diluted | -$1.31 | -$1.49 | -$0.75 | -$1.32 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 5, 2016 · 35 d after period end
